A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis

Trial Profile

A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2017

At a glance

  • Drugs Rituximab (Primary) ; Methylprednisolone; Prednisone
  • Indications Microscopic polyangiitis; Wegener's granulomatosis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 15 Jun 2017 Planned End Date changed from 1 Apr 2018 to 30 Jun 2021.
    • 15 Jun 2017 Planned primary completion date changed from 1 Apr 2018 to 30 Jun 2021.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top